Juvenile Idiopathic Arthritis Clinical Trial
Official title:
Massage Therapy for Children With Juvenile Idiopathic Arthritis Experiencing Pain: a Pilot Randomized Controlled Trial
While there has been progress in juvenile idiopathic arthritis (JIA) management, there is no
cure. Despite receiving standard of care, many children live with pain. Thus, it is not
surprising that families turn to complementary and alternative medicines (CAM) therapies,
including massage therapy (MT). Little is known about the efficacy of MT in JIA.
In this project, a massage therapist will teach parents how to provide a massage to their
child with JIA at bedtime, at home. The feasibility of establishing a home MT program for
children with JIA will be evaluated. In addition, the effects of MT on JIA will be examined.
This proposal is relevant to JIA families, who ask questions on MT to professionals of the
JIA clinic.
Beyond providing education to JIA families, this project demonstrates the team approach to
JIA management. Team members will include a pediatric rheumatology nurse and a massage
therapist.
While research breakthroughs have led to improved outcomes, many patients with JIA live with
pain. There is an association between daily fluctuations in JIA symptoms (pain, stiffness and
fatigue), and worse mood and stressful events, supporting the utility of daily diaries to
analyze JIA symptoms. Sleep disturbances have been demonstrated in JIA and are linked to the
pain experience. Ultimately, pain impacts on HRQoL. JIA families explore complementary and
alternative medicines such as MT, in addition to using conventional medicines, to help manage
the daily JIA symptoms. MT's effects on pain, mood, anxiety, stress and sleep have been
demonstrated in several diseases, possibly through modulation of neurological, endocrine and
immune processes. Children with JIA and pain could benefit from MT given with standard care.
Only one study evaluated its benefits in JIA. More research is needed on the feasibility,
efficacy and safety of MT in JIA. MT is available at the Montreal Children's Hospital in
Oncology. While offering MT in the hospital setting is practical for oncology patients who
require frequent hospitalizations, MT may be more beneficial for JIA patients if implemented
at home.
Objectives The primary purpose of this single center, pilot randomized controlled trial
(pilot RCT) is to determine the feasibility of a home MT program for children with JIA
experiencing pain. The second purpose is to determine the effects of MT primarily on daily
pain, as well as, other daily JIA symptoms (stiffness and fatigue), sleep quality,
health-related quality of life (HRQoL) and disease activity, and on caregiver's psychological
distress. The effects of MT on pro-inflammatory cytokines (IL-6, 17A, TNF) will be explored.
Methodology During the pilot RCT (Part 1), 30 children with JIA who experience pain will be
randomized to the experimental group (home MT and standard care) or control group (standard
care). After receiving training by the massage therapist, caregivers of the experimental
group will gently massage their child, for 15 minutes at bedtime, every night, at home.
Immediately after the RCT, participants of the control group will receive training and
implement home MT, similar to the experimental group, in an extension (Part 2).
Feasibility will be evaluated by the recruitment rate, retention rate, program adherence,
piloting of the intervention, and user acceptability and satisfaction with the program.
Given the daily fluctuations in JIA symptoms, daily pain, fatigue, stiffness and sleep
quality will be evaluated through multiple measurements with daily diaries to be completed by
patients and their caregivers, both before and after implementation of home MT in both
groups. Sleep, fatigue, HRQoL, disease activity and caregiver's psychological distress will
also be evaluated before and after implementation of home MT in both groups, with
questionnaires, physical examinations and blood samples.
Conclusion The findings from this project will provide the framework for planning a
multi-center study whose focus will be on the efficacy of MT in JIA. MT programs do not exist
in Canadian pediatric rheumatology centres and thus, this project is innovative. If there is
preliminary evidence that MT helps reduce pain, it could become an additional strategy to
help these children have a better HRQoL, with less pain and improved health outcomes. Parents
could feel empowered by participating concretely and in a positive way in the management of
their child's condition.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02776735 -
An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
|
Phase 2 | |
Active, not recruiting |
NCT03092427 -
Probiotic Treatment in Juvenile Idiopathic Arthritis (JIA)
|
N/A | |
Not yet recruiting |
NCT05545098 -
MSUS Versus Serum Survivin and Lubricin Levels in Evaluation of Disease Activity in JIA
|
||
Not yet recruiting |
NCT03833609 -
Yoga and Aerobic Dance for Pain Management in Juvenile Idiopathic Arthritis
|
N/A | |
Completed |
NCT02524340 -
Patient Centered Adaptive Treatment Strategies Using Bayesian Causal Inference
|
||
Recruiting |
NCT01434082 -
Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
|
N/A | |
Completed |
NCT04671524 -
The Effect of Improvement in Function on Foot Pressure, Balance and Gait in Children With Upper Extremity Affected
|
N/A | |
Recruiting |
NCT04167488 -
Assessment of Physical Activity Among Juvenile Idiopathic Arthritis Children Performed With Actigraphy
|
N/A | |
Recruiting |
NCT04205500 -
Treatment With Specific Carbohydrate Diet in Children With Juvenile Idiopathic Arthritis
|
N/A | |
Terminated |
NCT01694264 -
Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
|
Phase 3 | |
Completed |
NCT02824978 -
Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?
|
||
Active, not recruiting |
NCT03841357 -
Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA)
|
Phase 3 | |
Completed |
NCT03833271 -
The Efficacy of Influenza Vaccine Program in Children With Juvenile Idiopathic Arthritis. A Single Centre Results From Hungary
|
Early Phase 1 | |
Completed |
NCT01455701 -
A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
|
Phase 1 | |
Completed |
NCT05031104 -
Low-energy Laser Applications in Patients With Juvenile Idiopathic Arthritis
|
N/A | |
Not yet recruiting |
NCT01436019 -
Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
|
N/A | |
Recruiting |
NCT05609630 -
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
|
Phase 3 | |
Recruiting |
NCT05696340 -
Access to Pediatric Rheumatology Centers for JIA Patients: Factors Associated With Time to Access Pediatric Rheumatology Centers
|
||
Recruiting |
NCT05545839 -
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
|
N/A | |
Completed |
NCT05436301 -
Turkish Validity and Reliability of Pain Catastrophizing Scale-Child (PCS-C)
|